Literature DB >> 17947924

Cerebral embolization in patients undergoing protected carotid-artery stenting and carotid surgery.

V Faraglia1, G Palombo, N Stella, M Taurino, M L Iocca, A Romano, A Bozzao.   

Abstract

AIM: Intraoperative cerebral embolization is a greater concern in patients undergoing carotid-artery stenting (CAS) than in those undergoing the reference standard treatment carotid endarterectomy (CEA). We evaluated cerebral embolism with diffusion-weighted magnetic resonance imaging (DW-MRI) and transcranial Doppler monitoring during CAS and CEA.
METHODS: A series of 75 patients with carotid stenosis, 40 undergoing CEA and 35 transfemoral protected CAS, underwent preoperative and postoperative cerebral DW-MRI. Of the 75 patients, 64 (85%) underwent intraoperative transcranial Doppler monitoring to evaluate the mean number of microembolic signals (MES) recorded in each procedure.
RESULTS: None of the patients died. No patient in the CEA but two in the CAS group had strokes (5.7%, P=NS). The mean MES count on transcranial Doppler monitoring was higher in the CAS than in the CEA group (330.0 MES, range 2754 vs 13.2, range 0-49 MES; P<0.01). DW-MRI disclosed a significantly larger number of new ischemic lesions in the CAS than in the CEA group (40 lesions in 12/35 patients, 34.3% vs 4 lesions in 3/40 patients, 7.5%; P<0.01). In the CEA group, all patients with ischemic lesions were asymptomatic whereas in the CAS group 5 were symptomatic (14.3%) and 7 asymptomatic (20%). The cerebral distribution also differed in the two groups: no CEA but 20% of CAS lesions were contralateral.
CONCLUSION: CAS is associated with a significantly higher rate of cerebral embolization than CEA. Even though the clinical meaning of new postoperative ischemic lesions remains debatable, it seems prudent to reduce the embolic load by improving procedural techniques and cerebral protection devices.

Entities:  

Mesh:

Year:  2007        PMID: 17947924

Source DB:  PubMed          Journal:  J Cardiovasc Surg (Torino)        ISSN: 0021-9509            Impact factor:   1.888


  6 in total

1.  New ischemic brain lesions on diffusion-weighted MRI after carotid artery stenting with filter protection: frequency and relationship with plaque morphology.

Authors:  D Stojanov; M Ilic; P Bosnjakovic; M Zivkovic; S Jolic; N Vukasinovic; A Ignjatovic; B Ilic; D Benedeto-Stojanov
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-22       Impact factor: 3.825

2.  Volume of subclinical embolic infarct correlates to long-term cognitive changes after carotid revascularization.

Authors:  Wei Zhou; Brittanie D Baughman; Salil Soman; Max Wintermark; Laura C Lazzeroni; Elizabeth Hitchner; Jyoti Bhat; Allyson Rosen
Journal:  J Vasc Surg       Date:  2016-12-23       Impact factor: 4.268

3.  Prospective neurocognitive evaluation of patients undergoing carotid interventions.

Authors:  Wei Zhou; Elizabeth Hitchner; Kathleen Gillis; Lixian Sun; Rebecca Floyd; Barton Lane; Allyson Rosen
Journal:  J Vasc Surg       Date:  2012-08-11       Impact factor: 4.268

4.  Silent brain infarcts on diffusion-weighted imaging after carotid revascularisation: A surrogate outcome measure for procedural stroke? A systematic review and meta-analysis.

Authors:  Christopher Traenka; Stefan T Engelter; Martin M Brown; Joanna Dobson; Chris Frost; Leo H Bonati
Journal:  Eur Stroke J       Date:  2019-01-15

5.  New cerebral lesions at magnetic resonance imaging after carotid artery stenting versus endarterectomy: an updated meta-analysis.

Authors:  Giuseppe Gargiulo; Anna Sannino; Eugenio Stabile; Cinzia Perrino; Bruno Trimarco; Giovanni Esposito
Journal:  PLoS One       Date:  2015-05-27       Impact factor: 3.240

Review 6.  Systematic Review and Meta-Analysis of Carotid Artery Stenting Versus Endarterectomy for Carotid Stenosis: A Chronological and Worldwide Study.

Authors:  Lei Zhang; Zhiqing Zhao; Yaoming Ouyang; Junmin Bao; Qingsheng Lu; Rui Feng; Jian Zhou; Zaiping Jing
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.